Literature DB >> 25634648

Epithelial ovarian cancers and endometriosis.

Pedro Acién1, Irene Velasco, Maribel Acién, Cecilia Capello, Pilar Vela.   

Abstract

AIMS: To determine the prevalence of endometriosis in epithelial ovarian cancers (EOC) and the association among their histological subtypes and with endometrial carcinoma.
METHODS: An observational cohort study performed in 192 patients operated on for EOC, 30 women with atypical endometriosis and 17 with p53 positive endometriosis. Data on associated endometriosis and endometrial carcinomas, histological subtypes, tumor stage, clinical and pathological characteristics and survival were analyzed.
RESULTS: Twenty cases of EOC (10.4%) had also endometriosis (12.7 in borderline and 9.3% in invasive cases), being a synchronous finding in most cases. Endometriosis associated with serous or mucinous EOC was observed in 2.2 and 2.7% of cases, respectively. However, this association was observed in 50 of endometrioid and 23% of clear cell EOC. Age, parity and tumor stage were lower in endometriosis-associated EOC patients; and all associated cases were type I (Kurman and Shih's classification) and showed better results in survival rate. Endometrial carcinoma was more frequently associated with endometrioid EOC (25%).
CONCLUSIONS: There is a significant association between endometriosis, including atypical forms, and endometrioid and clear cell carcinomas, but not with other EOC histotypes. The presence of endometriosis in EOC suggests a better prognosis and an intermediate stage within the progression endometriosis-carcinoma.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 25634648     DOI: 10.1159/000367597

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  7 in total

Review 1.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

2.  Endometriosis and Ovarian Cancer: an Integrative Review (Endometriosis and Ovarian Cancer)

Authors:  Aline Veras Morais Brilhante; Kathiane Lustosa Augusto; Manuela Cavalcante Portela; Luiz Carlos Gabriele Sucupira; Luiz Adriano Freitas Oliveira; Ana Juariana Magalhães Veríssimo Pouchaim; Lívia Rocha Mesquita Nóbrega; Thaís Fontes de Magalhães; Leonardo Robson Pinheiro Sobreira
Journal:  Asian Pac J Cancer Prev       Date:  2017-01-01

3.  Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer.

Authors:  Isabel Ñiguez Sevilla; Francisco Machado Linde; Maria Del Pilar Marín Sánchez; Julián Jesús Arense; Amparo Torroba; Anibal Nieto Díaz; Maria Luisa Sánchez Ferrer
Journal:  J Gynecol Oncol       Date:  2019-03-04       Impact factor: 4.401

4.  Analysis of differences in the transcriptomic profiles of eutopic and ectopic endometriums in women with ovarian endometriosis.

Authors:  Jinfeng Xue; Xiaowen Tong; Xiao Feng; Lingbin Qi; Xiaoyu Xu; Yun Feng; Xiaoming Gong; Aixingzi Aili; Yu Chen; Zhigang Xue
Journal:  PeerJ       Date:  2021-04-07       Impact factor: 2.984

5.  Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.

Authors:  Bingjian Lu; Qin Chen; Xiaofei Zhang; Lili Cheng
Journal:  Diagn Pathol       Date:  2016-06-04       Impact factor: 2.644

6.  Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma.

Authors:  Tong Ren; Shu Wang; Jian Sun; Ji-Min Qu; Yang Xiang; Keng Shen; Jing He Lang
Journal:  J Ovarian Res       Date:  2017-10-03       Impact factor: 4.234

7.  GRN, NOTCH3, FN1, and PINK1 expression in eutopic endometrium - potential biomarkers in the detection of endometriosis - a pilot study.

Authors:  Isabell Holzer; Amanda Machado Weber; Anne Marshall; Alexander Freis; Julia Jauckus; Thomas Strowitzki; Ariane Germeyer
Journal:  J Assist Reprod Genet       Date:  2020-10-07       Impact factor: 3.412

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.